Smoking-related small airway disease-a review and update

Advances in Anatomic Pathology

Volumn 17, Issue 4, 2010, Pages 270-276

  Beasley, Mary Beth ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

bronchiolitis; chronic obstructive pulmonary disease; emphysema; Langerhans cell histiocytosis; respiratory bronchiolitis; small airway disease; smoking related interstitial lung disease

Indexed keywords

AIRWAY OBSTRUCTION; BRONCHIOLITIS; COUGHING; DISEASE ASSOCIATION; DYSPNEA; EMPHYSEMA; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SMALL AIRWAY DISEASE; SMOKING;

ADULT; AIRWAY REMODELING; BRONCHIOLITIS; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG DISEASES; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 77954489481     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181e3bf97     Document Type: Review

References (48)

1. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978;298:1277-1281. (Pubitemid 8361451)
2. Gelb AF, Hogg JC, Muller NL, et al. Contribution of emphysema and small airways in COPD. Chest. 1996;109: 353-359. (Pubitemid 26058588)
3. Rice A, Nicholson AG. The pathologist's approach to small airways disease. Histopathology. 2009;54:117-133.
4. Allen TC. Pathology of small ariways disease. Archives Pathol Lab Med. 2010;134:702-718.
5. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278:1355-1360.
6. Hogg JC. State of the art. Bronchiolitis in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3:489-493. (Pubitemid 44285530)
7. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364:709-721. (Pubitemid 39140629)
8. Hogg JC. Chronic obstructive pulmonary disease: an overview of pathology and pathogenesis. Novartis Found Symp. 2001;234:4-19; discussion 19-26. (Pubitemid 32172948)
9. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645-2653. (Pubitemid 38787999)
10. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435-459.
11. Wright JL. Chronic airflow obstruction. In: Churg A, Myers J, Tazelaar H, et al, eds. Thurlbeck's Pathology of the Lung. 3rd ed. New York: Thieme; 2005:675-741.
12. Wiggs BR, Bosken C, Pare PD, et al. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;145:1251-1258.
13. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med. 2001;164(10 Pt 2): S28-S38.
14. Wright JL, Hobson JE, Wiggs B, et al. Airway inflammation and peribronchiolar attachments in the lungs of nonsmokers, current and ex-smokers. Lung. 1988;166:277-286.
15. Linhartova A, Anderson AE Jr, Foraker AG. Topology of nonrespiratory bronchioles of normal and emphysematous lungs. Hum Pathol. 1974;5:729-735.
16. Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2002;166:329-332. (Pubitemid 34864421)
17. Mullen JB, Wright JL, Wiggs BR, et al. Reassessment of inflammation of airways in chronic bronchitis. Br Med J (Clin Res Ed). 1985;291:1235-1239. (Pubitemid 16223211)
18. Hogg JC, Senior RM. Chronic obstructive pulmonary disease-part 2: pathology and biochemistry of emphysema. Thorax. 2002;57:830-834. (Pubitemid 34984984)
19. Shapiro SD, Ingenito EP. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol. 2005;32:367-372. (Pubitemid 40629320)
20. Cosio MG, Majo J. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest. 2002;121(5 suppl): 160S-165S. (Pubitemid 34497335)
21. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22:672-688. (Pubitemid 37258549)
22. Churg A, Tai H, Coulthard T, et al. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med. 2006;174:1327-1334. (Pubitemid 44913034)
23. Wang RD, Wright JL, Churg A. Transforming growth factor-beta1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol. 2005;33:387-393. (Pubitemid 41416289)
24. Vignola AM, Chanez P, Chiappara G, et al. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med. 1997; 156(2 Pt 1):591-599. (Pubitemid 27352000)
25. Takizawa H, Tanaka M, Takami K, et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 2001; 163:1476-1483. (Pubitemid 32506619)
26. Kenyon NJ, Ward RW, McGrew G, et al. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax. 2003;58:772-777. (Pubitemid 37094053)
27. Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol. 2005;33: 9-13. (Pubitemid 40961008)
28. Gauldie J, Kolb M, Sime PJ. A new direction in the pathogenesis of idiopathic pulmonary fibrosis? Respir Res. 2002;3:1.
29. Churg A, Zhou S, Preobrazhenska O, et al. Expression of profibrotic mediators in small airways versus parenchyma after cigarette smoke exposure. Am J Respir Cell Mol Biol. 2009; 40:268-276.
30. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med. 1974;291:755-758.
31. Myers JL, Veal CF Jr, Shin MS, et al. Respiratory bronchiolitis causing interstitial lung disease. A clinicopatho-logic study of six cases. Am Rev Respir Dis. 1987;135: 880-884.
32. Ryu JH, Myers JL, Capizzi SA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest. 2005;127:178-184. (Pubitemid 41724574)
33. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchio-litis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc. 1989;64: 1373-1380.
34. Rao RN, Goodman LR, Tomashefski JF Jr. Smoking-related interstitial lung disease. Ann Diagn Pathol. 2008;12:445-457.
35. Fraig M, Shreesha U, Savici D, et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol. 2002;26:647-653. (Pubitemid 34438725)
36. Yousem SA. Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol. 2006;19:1474-1479.
37. Katzenstein AL, Mukhopadhyay S, Zanardi C, et al. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol. 2010;41:316-325.
38. Kawabata Y, Hoshi E, Murai K, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology. 2008;53:707-714. (Pubitemid 352768716)
39. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore). 1981;60:385-396.
40. Vassallo R, Limper AH. Pulmonary Langerhans' cell histio-cytosis. Semin Respir Crit Care Med. 2002;23:93-101.
41. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X)\a clonal proliferative disease. N Engl J Med. 1994;331:154-160. (Pubitemid 24209565)
42. Willman CL. Detection of clonal histiocytes in Langerhans cell histiocytosis: biology and clinical significance. Br J Cancer Suppl. 1994;23:S29-S33.
43. Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol. 2001;25:630-636. (Pubitemid 32423361)
44. Yu RC, Chu C, Buluwela L, et al. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet. 1994;343:767-768. (Pubitemid 24098697)
45. Caminati A, Harari S. Smoking-related interstitial pneumonias and pulmonary Langerhans cell histiocytosis. Proc Am Thorac Soc. 2006;3:299-306. (Pubitemid 43845406)
46. Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med. 2002;346:484-490. (Pubitemid 34441739)
47. Allen TC. Pulmonary langerhans cell histiocytosis and other pulmonary histiocytic diseases: a review. Archives Pathol Lab Med. 2008;132:1171-1181. (Pubitemid 351955744)
48. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol. 1993;17:971-986. (Pubitemid 23289339)